Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Glycopyrrolate Patent Expiration

Glycopyrrolate is Used for managing chronic obstructive pulmonary disease (COPD) through maintenance treatment of airflow obstruction. It was first introduced by Casper Pharma Llc in its drug Robinul on Approved Prior to Jan 1, 1982. Other drugs containing Glycopyrrolate are Seebri, Lonhala Magnair Kit, Glycopyrrolate, Dartisla Odt, Glyrx-Pf, Robinul Forte, Cuvposa. 53 different companies have introduced drugs containing Glycopyrrolate.


Glycopyrrolate Patents

Given below is the list of patents protecting Glycopyrrolate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lonhala Magnair Kit US10744277 Aerosol delivery device and method of operating the aerosol delivery device Dec 07, 2036 Sumitomo Pharma Am
Lonhala Magnair Kit US10688518 Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator Nov 12, 2036 Sumitomo Pharma Am
Lonhala Magnair Kit US10376661 Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element Sep 14, 2035 Sumitomo Pharma Am
Lonhala Magnair Kit US9604018 Aerosol therapy device May 16, 2033 Sumitomo Pharma Am
Lonhala Magnair Kit US9168556 Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer Sep 01, 2032 Sumitomo Pharma Am
Lonhala Magnair Kit US9789270 Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized Oct 30, 2030 Sumitomo Pharma Am
Lonhala Magnair Kit US10940110 Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations Feb 26, 2029 Sumitomo Pharma Am
Lonhala Magnair Kit US9265900 Disposable ampoule for an aerosol generating device Dec 07, 2028 Sumitomo Pharma Am
Seebri US8182838 Dry powder composition comprising co-jet milled particles for pulmonary inhalation Oct 20, 2028 Novartis
Seebri US8479730 Inhaler device Oct 11, 2028 Novartis
Lonhala Magnair Kit US11278683 Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized Aug 16, 2026 Sumitomo Pharma Am
Lonhala Magnair Kit US7931212 Fluid droplet production apparatus and method Nov 25, 2025 Sumitomo Pharma Am
Lonhala Magnair Kit US7458372 Inhalation therapy device Nov 18, 2024

(Expired)

 Sumitomo Pharma Am
Robinul US7091236 Method for increasing the bioavailability of glycopyrrolate Apr 24, 2024

(Expired)

 Casper Pharma Llc
Robinul Forte US7091236 Method for increasing the bioavailability of glycopyrrolate Apr 24, 2024

(Expired)

 Casper Pharma Llc
Lonhala Magnair Kit US8511581 Fluid droplet production apparatus and method Nov 08, 2023

(Expired)

 Sumitomo Pharma Am
Cuvposa US7638552 Method for increasing the bioavailability of glycopyrrolate Aug 20, 2023

(Expired)

 Merz Pharms
Cuvposa US7816396 Method for increasing the bioavailability of glycopyrrolate Aug 20, 2023

(Expired)

 Merz Pharms
Lonhala Magnair Kit US7316067 Forming a perforate membrane by laser drilling and a subsequent electro-polishing step Sep 06, 2022

(Expired)

 Sumitomo Pharma Am
Seebri US7736670 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

 Novartis
Seebri US8048451 Pharmaceutical compositions for inhalation Jun 27, 2021

(Expired)

 Novartis
Seebri US8303991 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

 Novartis
Seebri US8435567 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation Jun 27, 2021

(Expired)

 Novartis
Seebri US8580306 Particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

 Novartis
Seebri US8956661 Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof Jun 27, 2021

(Expired)

 Novartis
Seebri US9931304 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

 Novartis
Seebri US9962338 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

 Novartis
Seebri US7229607 Treatment of respiratory disease Apr 09, 2021

(Expired)

 Novartis
Seebri US8029768 Treatment of respiratory diseases Apr 09, 2021

(Expired)

 Novartis
Lonhala Magnair Kit US6962151 Inhalation nebulizer Oct 27, 2020

(Expired)

 Sumitomo Pharma Am
Seebri US6528678 Phosgene-free process for preparing carbamates Apr 24, 2018

(Expired)

 Novartis
Seebri US6582678 Carrier particles for use in dry powder inhalers Apr 24, 2018

(Expired)

 Novartis
Seebri US6521260 Carrier particles for use in dry powder inhalers Jan 31, 2016

(Expired)

 Novartis



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Glycopyrrolate's patents.

Given below is the list recent legal activities going on the following patents of Glycopyrrolate.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed
Critical
 24 Jun, 2024 US8303991(Litigated)
Expire Patent
Critical
 04 Dec, 2023 US8048451
Maintenance Fee Reminder Mailed
Critical
 19 Jun, 2023 US8048451
Expire Patent
Critical
 27 Mar, 2023 US8956661
Payment of Maintenance Fee, 12th Year, Large Entity 22 Mar, 2023 US8029768
Maintenance Fee Reminder Mailed
Critical
 10 Oct, 2022 US8956661
Expire Patent
Critical
 18 Jul, 2022 US7736670
Expire Patent
Critical
 13 Jun, 2022 US9962338
Expire Patent
Critical
 10 May, 2022 US9931304
Maintenance Fee Reminder Mailed
Critical
 31 Jan, 2022 US7736670


Glycopyrrolate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glycopyrrolate Generic API Manufacturers

Several generic applications have been filed for Glycopyrrolate. The first generic version for Glycopyrrolate was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Apr 8, 2025.

Given below is the list of companies who have filed for Glycopyrrolate generic, along with the locations of their manufacturing plants worldwide.


1. ABRAXIS PHARM

Abraxis Pharmaceutical Products has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Jun 12, 1984





2. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Jul 8, 2020





3. ADAPTIS

Adaptis Pharma Private Ltd has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Adaptis.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Feb 3, 2014
1MG

tablet Prescription ORAL AA Feb 3, 2014





4. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Nov 30, 2018
1MG

tablet Prescription ORAL AA Nov 30, 2018
0.2MG/ML

injectable Prescription INJECTION AP Oct 26, 2022


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Vadodara Alembic Pharmaceuticals Ltd
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panelav Alembic Pharmaceuticals Limited





5. AM REGENT

American Regent Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Jul 23, 1986





6. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 21, 2022


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Hauppauge Amneal Pharmaceuticals of New York, LLC
Paterson Amneal Pharmaceuticals, Llc
Glasgow Amneal Pharmaceuticals LLC
Branchburg Amneal Pharmaceuticals, LLC
Piscataway Amneal Pharmaceuticals, LLC
East Hanover Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.





7. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Jul 5, 2022


Manufacturing Plant Locations
New

Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Annora Pharma Private Limited





8. APOTEX

Apotex Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 29, 2019


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
Brantford Apotex Pharmachem Inc.
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





9. APPCO

Appco Pharma Llc has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Appco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AA Jan 3, 2017
2MG

tablet Prescription ORAL AA Jan 3, 2017


Manufacturing Plant Locations
New

Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.

Country City Firm Name
United States
Somerset Appco Pharma, LLC
Piscataway Appco Pharma LLC





10. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AA Apr 15, 2013
2MG

tablet Prescription ORAL AA Oct 30, 2018


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Sangareddy Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





11. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Dec 31, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





12. CAPLIN

Caplin Steriles Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Mar 20, 2019


Manufacturing Plant Locations
New

Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.

Country City Firm Name
United States
Creve Coeur Caplin, Dr David
India
Gummidipoondi Caplin Steriles Limited





13. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AA Mar 21, 2008
2MG

tablet Prescription ORAL AA Mar 21, 2008
1MG/5ML

solution Prescription ORAL AA Aug 28, 2024





14. ENDO OPERATIONS

Endo Operations Ltd has filed for 3 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

(reference standard)

tablet Prescription ORAL AA Aug 31, 2006
1MG

(reference standard)

tablet Prescription ORAL AA Aug 31, 2006
1MG/5ML

solution Prescription ORAL AA Aug 9, 2021





15. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Nov 28, 2018


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





16. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 31, 2018


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Lake Zurich Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Wilson Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC





17. GLAND

Gland Pharma Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Sep 30, 2019


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Visakhapatnam Gland Pharma Limited
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Malur Gland Chemicals Pvt Ltd.
Sriperumbudur Gland Chemical Private Limited
Aurangabad Gland Chemical Private Limited
Hyderabad Gland Pharma Limited
Parawada, Visakhapatnam Gland Pharma Limited





18. GRANULES

Granules Pharmaceuticals Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Aug 19, 2024


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Manassas Granules Consumer Health Inc.
Chantilly Granules Pharmaceuticals Inc.
India
Secunderabad Granules India Limited
Parawada Mandal Granules India Limited
Visakhapatnam Granules India Limited
Medchal-Malkhajgiri District Granules India Limited
Sangareddy District Granules India Limited





19. HIKMA FARMACEUTICA

Hikma Farmaceutica (portugal) Sa has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

(reference standard)

injectable Prescription INJECTION AP Sep 21, 2011


Manufacturing Plant Locations
New

Hikma Farmaceutica's manufacturing plants are situated in 1 country - Portugal. Given below are the details of these plant locations as well as the firm names of Hikma Farmaceutica as present at those locations.

Country City Firm Name
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.





20. HIKMA INTL PHARMS

Hikma International Pharmaceuticals Llc has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Discontinued ORAL N/A Mar 5, 2009
2MG

tablet Discontinued ORAL N/A Mar 5, 2009





21. HOSPIRA

Hospira Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Jun 15, 1988


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Morgan Hill Hospira Inc
Clayton Hospira, Inc.
Mcpherson Hospira, Inc., A Pfizer Company
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Lake Forest Hospira Inc
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





22. LGM PHARMA

Lgm Pharma Solutions Llc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Lgm Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

(reference standard)

tablet Prescription ORAL N/A Mar 12, 2012


Manufacturing Plant Locations
New

Lgm Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Lgm Pharma as present at those locations.

Country City Firm Name
United States
Rosenberg LGM Pharma Solutions LLC
Erlanger LGM Pharma LLC
Boca Raton LGM Pharma, LLC
Irvine LGM Pharma Solutions, LLC





23. LUPIN LTD

Lupin Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Feb 7, 2023


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





24. MANKIND PHARMA

Mankind Pharma Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Feb 27, 2023


Manufacturing Plant Locations
New

Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.

Country City Firm Name
India
Imt Manesar Mankind Pharma Limited
Paonta Sahib Mankind Pharma Limited





25. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Jul 6, 2021





26. MSN

Msn Laboratories Private Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Apr 8, 2025


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Isnapur MSN Laboratories Private Limited, Unit-II
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Rangareddy District MSN Laboratories Private Limited
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
Sangareddy MSN Laboratories Private Limited, R&D Center
Sangareddy MSN Pharmachem Private Limited
Sangareddy MSN Laboratories Private Ltd.
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Yadadri Bhuvanagiri District MSN Organics Private Limited
Kamareddy MSN Life Sciences Private Limited
United States
Piscataway MSN PHARMACEUTICALS INC





27. NATCO

Natco Pharma Ltd has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Natco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Jun 20, 2016
1MG

tablet Prescription ORAL AA Jun 20, 2016


Manufacturing Plant Locations
New

Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.

Country City Firm Name
United Kingdom
Hayes Natco Cash and Carry
Buckingham Natco Foods Ltd
India
Paravada Natco Pharma Limited
Hyderabad Natco Pharma Limited
Hyderabad NATCO PHARMA LTD
Rangareddy NATCO Pharma Limited
Chennai NATCO Pharma Limited Chemical Division Chennai
Rangareddy District Natco Pharma Ltd. - Chemical Division





28. OMNIVIUM PHARMS

Omnivium Pharmaceuticals Llc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Omnivium Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Nov 29, 2022





29. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Oct 19, 2011
1MG

tablet Prescription ORAL AA Oct 19, 2011





30. PIRAMAL CRITICAL

Piramal Critical Care Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Piramal Critical.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 25, 2018


Manufacturing Plant Locations
New

Piramal Critical's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Piramal Critical as present at those locations.

Country City Firm Name
United States
Bethlehem Piramal Critical Care, Inc.





31. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 31, 2018





32. QUAGEN

Quagen Pharmaceuticals Llc has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Quagen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Jul 10, 2024
1MG

tablet Prescription ORAL AA Jul 10, 2024


Manufacturing Plant Locations
New

Quagen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Quagen as present at those locations.

Country City Firm Name
United States
West Caldwell Quagen Pharmacuticals, LLC
West Caldwell Quagen Pharma, LLC





33. RISING

Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AA Dec 29, 2008
2MG

tablet Prescription ORAL AA Dec 29, 2008


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Phoenix Rising Sun Farms Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Fort Bragg Rising Tide Sea Vegetables
Rising Sun Rising Sun Veterinary Clinic
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





34. SAGENT

Sagent Pharmaceuticals has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Sagent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Feb 21, 2020


Manufacturing Plant Locations
New

Sagent's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sagent as present at those locations.

Country City Firm Name
United States
Schaumburg Sagent Pharmaceuticals





35. SANDOZ

Sandoz Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP May 14, 2019


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





36. SAPTALIS PHARMS

Saptalis Pharmaceuticals Llc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Saptalis Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Oct 7, 2024





37. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Jun 23, 2017





38. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AA Aug 18, 2009
1MG

tablet Prescription ORAL AA Aug 18, 2009





39. SUVEN PHARMS

Suven Pharmaceuticals Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Suven Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/5ML

solution Prescription ORAL AA Jul 5, 2022





40. TEVA PARENTERAL

Teva Parenteral Medicines Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Teva Parenteral.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Sep 10, 1991


Manufacturing Plant Locations
New

Teva Parenteral's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Teva Parenteral as present at those locations.

Country City Firm Name
United States
Irvine Teva Parenteral Medicines, Inc.





41. UMEDICA

Umedica Laboratories Private Ltd has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Umedica.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Prescription INJECTION AP Oct 13, 2021


Manufacturing Plant Locations
New

Umedica's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Umedica as present at those locations.

Country City Firm Name
India
Vapi Umedica Laboratories Pvt. Ltd.





42. VELZEN PHARMA PVT

Velzen Pharma Pvt Ltd has filed for 2 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Velzen Pharma Pvt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AA Sep 21, 2012
2MG

tablet Prescription ORAL AA Sep 21, 2012





43. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
2MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.2MG/ML

injectable Discontinued INJECTION N/A Jun 24, 1983





44. XIROMED

Xiromed Pharma Espana Sl has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Mar 4, 2021


Manufacturing Plant Locations
New

Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.

Country City Firm Name
United States
Florham Park XIROMED LLC





45. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Glycopyrrolate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.2MG/ML

injectable Discontinued INJECTION N/A Nov 9, 2021